Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05164536 · ClinicalTrials.gov registry record · Phase 1
Plasma P-tau2017 and Quantitative Amyloid PET Imaging
A Phase 1 study, sponsored by Invicro.
- Completed
- Registry status
- Phase 1
- Development phase
- 140
- Enrollment target
NCT05164536 is a Phase 1 study that has completed, run by Invicro. The registered enrollment target is 140 participants.
The verdict
NCT05164536, a Phase 1 study, has completed, sponsored by Invicro.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 140 participants
- Enrollment target
Study Summary
The overall goal of this protocol is to compare amyloid burden assessed by amyloid PET to plasma P-tau217 levels.
Interventions
- DRUG Amyvid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 140 participants |
| Start Date | 2021-08-27 |
| Est. Completion | 2022-11-08 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05164536
The ClinicalTrials.gov registry entry for NCT05164536 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 140 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Invicro, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Amyvid is the first listed.
NCT05164536 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05164536 about?
NCT05164536 is a clinical study titled "Plasma P-tau2017 and Quantitative Amyloid PET Imaging". The overall goal of this protocol is to compare amyloid burden assessed by amyloid PET to plasma P-tau217 levels.
What is the current status of trial NCT05164536?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 140 participants. The study started on 2021-08-27. Estimated completion is 2022-11-08.
What interventions are being tested in trial NCT05164536?
The interventions under investigation include: Amyvid (DRUG).
Who is sponsoring clinical trial NCT05164536?
This trial is sponsored by Invicro, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.